Dolby International v Beko Germany (CFI, 9 April 2025)
| Date | 9 April 2025 |
|---|---|
| Court | CFI |
| Division | Düsseldorf (DE) Local Division |
| Type of action | Application RoP262.1 (b) |
| Registry reference | App_7511/2025 · ORD_8911/2025 |
| Parties | Epson Deutschland GmbH |
Official decision (PDF) · UPC registry entry
Dhenne Avocats represents claimants and defendants in European patent disputes before the Unified Patent Court, including the Paris divisions.
Dhenne Avocats · 10 October 2026
Our analysis
Summary
By order of 9 April 2025 (UPC_CFI_135/2024 and UPC_CFI_477/2024, App_7511/2024), the Düsseldorf Local Division (Judges Thomas, presiding, Schumacher, rapporteur, Kokke and Matter) partly granted Epson Deutschland, a third party sued by Dolby before the Hamburg Local Division, access to five pleadings in Dolby International’s infringement action against Beko Germany and Arçelik on EP 3 605 534, said to be essential to the Opus standard. Only the passages on construction and validity remain visible, and Dolby must carry out the redaction.
Question
Does a defendant in a parallel action have a specific interest, while proceedings are pending, in access to pleadings and evidence, including on infringement and the FRAND defence?
Decision
Access is weighed against the interests listed in Art. 45 UPCA, including confidentiality and the integrity of proceedings. Before the first-instance decision, only a specific interest can justify it. Epson’s interest, as it must defend itself and may counterclaim in Hamburg, concerns the construction and validity of the patent. No such interest was shown for infringement, the mere common use of Android TV being insufficient, nor for the FRAND defence, on which Dolby raised serious concerns. The other pleadings and all exhibits were refused. Following Panasonic v OPPO, redaction is placed on the claimant, in its own interest.
Key points for practice
- Third-party access during proceedings is measured by the specific interest shown: a defendant in a parallel action obtains the arguments on construction and validity, not those on infringement or FRAND.
- The Düsseldorf Local Division places the redaction task on the party whose pleadings are disclosed.
Provisions applied
- Agreement on a Unified Patent Court
- Art. 45
- Rules of Procedure
- Rule 262.1(b)
- Case law cited
- Ocado Innovation v Autostore, Court of Appeal, 10 April 2024, Abbott Diabetes Care v Powell Gilbert, Court of Appeal, 9 January 2025, Astellas v Healios, Munich Local Division, 22 August 2024, Meril v Edwards, Paris Local Division, 14 October 2024, Regeneron v Amgen, Munich Local Division, 22 October 2024, NanoString v President and Fellows of Harvard College, Munich Local Division, 3 January 2025, Phoenix Contact v I.L.M.E., Munich Local Division, 20 December 2024, Swarco v Strabag, Vienna Local Division, 12 August 2024, Panasonic v OPPO, Mannheim Local Division, 26 March 2025
Prepared by Dhenne Avocats from the official decision, consulted on 10 October 2026. The database is updated every week, on Friday. Only the official text is authoritative.
Going further
Lexicon: Written procedure (UPC), Confidentiality club.
Source and translations
- Official source
- Unified Patent Court registry link recorded in the record
- Original language
- not recorded
- Translation available
- no translation recorded the firm’s French record is a summary, not a translation
- Date checked
- not recorded
Follow this case
Proceedings, related decisions, appeals, parties and patents as recorded in the registry and in the Dhenne Avocats corpus. Each link states its source.
Proceedings
Parties
- claimantEpson Deutschland GmbHFollow this party
Decisions in the same proceedings and documented appeals
Contents of the record
- Nature of the act
- Application RoP262.1 (b)
- Outcome (Dhenne Avocats summary)
- Epson obtient l'accès à cinq écritures limitées aux développements sur l'interprétation et la validité du brevet, l'expurgation incombant à Dolby. Le surplus est rejeté.
- Appeal
- No appeal documented in the corpus, this does not mean that no appeal was lodged.
- Instance
- First-instance decision, whether it has become final is not recorded.
Patents mentioned
EP 3 605 534mentioned in: Dhenne Avocats analysis Follow this patent
Related decisions cited in the analyses
- Abbott Diabetes Care v Powell Gilbert LLP (CoA, 9 January 2025) cited in this record
- Astellas Institute for Regenerative Medicine v Healios K.K (CFI, 22 August 2024) cited in this record
- Ocado Innovation v Autostore (CoA, 10 April 2024) cited in this record
Patents and standards
Receive an alert
Weekly summary of new records and substantive updates matching what you follow. Address confirmed by email, unsubscribe at any time, one email per week even where several of your follows match.